Despite the recent fall, the Nifty Midcap 100 index has outperformed by gaining 20 per cent till date in this year calendar year.
Despite the recent fall, the Nifty Midcap 100 index has outperformed by gaining 20 per cent till date in this year calendar year.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Quite a few large- and mid-cap stocks are yet to recover from the note ban, pharma, banking and rural demand-based industries among laggards.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Even as the Supreme Court had recently dismissed the industry's plea against prices fixed by the regulator and its timely implementation, the National Pharmaceutical Pricing Authority has asked companies to pay the overcharged dues with 15 per cent interest.
.jpg)
The move is expected to delay the introduction of low-priced medicines in the market.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Google has acquired Flutter, a San Francisco-based company founded by two persons of Indian origin - Navneet Dalal and Mehul Nariyawala.
Indian pharma firms under European drug regulator's scanner.
Financial shares were among the top Sensex gainers along with auto and pharma shares.
Fixed-dose combinations are medicines that come mixed in a certain proportion.
Can the poll outcome be a trigger for a meaningful correction?
Gujarat has around 3,000 licensees for allopathic drug manufacturing, apart from around seven homeopathic licensees, 500 ayuvedic and 600-700 cosmetics licensees
Natco Pharma, Wockhardt and Marksans have rallied between 50 and 70 per cent in the year till date.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances